BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 24139080)

  • 1. An update on the management of implanted cardiac devices during electrosurgical procedures.
    Parekh PJ; Buerlein RC; Shams R; Herre J; Johnson DA
    Gastrointest Endosc; 2013 Dec; 78(6):836-841. PubMed ID: 24139080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.
    Epstein AE; DiMarco JP; Ellenbogen KA; Estes NA; Freedman RA; Gettes LS; Gillinov AM; Gregoratos G; Hammill SC; Hayes DL; Hlatky MA; Newby LK; Page RL; Schoenfeld MH; Silka MJ; Stevenson LW; Sweeney MO; ; ;
    Circulation; 2013 Jan; 127(3):e283-352. PubMed ID: 23255456
    [No Abstract]   [Full Text] [Related]  

  • 3. Electromagnetic Interference with Protocolized Electrosurgery Dispersive Electrode Positioning in Patients with Implantable Cardioverter Defibrillators.
    Schulman PM; Treggiari MM; Yanez ND; Henrikson CA; Jessel PM; Dewland TA; Merkel MJ; Sera V; Harukuni I; Anderson RB; Kahl E; Bingham A; Alkayed N; Stecker EC
    Anesthesiology; 2019 Apr; 130(4):530-540. PubMed ID: 30601218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of electromagnetic interference on implanted cardiac devices and their management.
    Yerra L; Reddy PC
    Cardiol Rev; 2007; 15(6):304-9. PubMed ID: 18090066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of hyfrecators and their in vitro interference with implantable cardiac devices.
    Weyer C; Siegle RJ; Eng GG
    Dermatol Surg; 2012 Nov; 38(11):1843-8. PubMed ID: 22889152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obtaining rapid and effective hemostasis: Part II. Electrosurgery in patients with implantable cardiac devices.
    Howe N; Cherpelis B
    J Am Acad Dermatol; 2013 Nov; 69(5):677.e1-677.e9. PubMed ID: 24124835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients with pacemaker or implantable cardioverter-defibrillator.
    Schulman PM; Rozner MA; Sera V; Stecker EC
    Med Clin North Am; 2013 Nov; 97(6):1051-75. PubMed ID: 24182719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Electromagnetic interference : Pacemakers, cardiac resynchronization therapy devices, implantable cardioverter-defibrillator].
    Nowak B; Przibille O; Napp A
    Herzschrittmacherther Elektrophysiol; 2022 Sep; 33(3):297-304. PubMed ID: 35781834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.
    Epstein AE; DiMarco JP; Ellenbogen KA; Estes NA; Freedman RA; Gettes LS; Gillinov AM; Gregoratos G; Hammill SC; Hayes DL; Hlatky MA; Newby LK; Page RL; Schoenfeld MH; Silka MJ; Stevenson LW; Sweeney MO; Tracy CM; Epstein AE; Darbar D; DiMarco JP; Dunbar SB; Estes NA; Ferguson TB; Hammill SC; Karasik PE; Link MS; Marine JE; Schoenfeld MH; Shanker AJ; Silka MJ; Stevenson LW; Stevenson WG; Varosy PD; ; ;
    J Am Coll Cardiol; 2013 Jan; 61(3):e6-75. PubMed ID: 23265327
    [No Abstract]   [Full Text] [Related]  

  • 10. Implications of pacemakers and implantable cardioverter defibrillators in urological practice.
    Ubee SS; Kasi VS; Bello D; Manikandan R
    J Urol; 2011 Oct; 186(4):1198-205. PubMed ID: 21849189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Heart Rhythm Society (HRS)/American Society of Anesthesiologists (ASA) Expert Consensus Statement on the perioperative management of patients with implantable defibrillators, pacemakers and arrhythmia monitors: facilities and patient management: executive summary this document was developed as a joint project with the American Society of Anesthesiologists (ASA), and in collaboration with the American Heart Association (AHA), and the Society of Thoracic Surgeons (STS).
    Crossley GH; Poole JE; Rozner MA; Asirvatham SJ; Cheng A; Chung MK; Ferguson TB; Gallagher JD; Gold MR; Hoyt RH; Irefin S; Kusumoto FM; Moorman LP; Thompson A
    Heart Rhythm; 2011 Jul; 8(7):e1-18. PubMed ID: 21722852
    [No Abstract]   [Full Text] [Related]  

  • 12. Electrosurgery in patients with pacemakers/implanted cardioverter defibrillators.
    Dawes JC; Mahabir RC; Hillier K; Cassidy M; de Haas W; Gillis AM
    Ann Plast Surg; 2006 Jul; 57(1):33-6. PubMed ID: 16799305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interference of remote magnetic catheter navigation and ablation with implanted devices for pacing and defibrillation.
    Lüthje L; Vollmann D; Seegers J; Sohns C; Hasenfuss G; Zabel M
    Europace; 2010 Nov; 12(11):1574-80. PubMed ID: 20810533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An in vitro evaluation of electromagnetic interference between implantable cardiac devices and ophthalmic laser systems.
    Sher NA; Golben MP; Kresge K; Selznick L; Adabag S
    Europace; 2011 Apr; 13(4):583-8. PubMed ID: 21252191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electromagnetic interference and implanted cardiac devices: the nonmedical environment (part I).
    Misiri J; Kusumoto F; Goldschlager N
    Clin Cardiol; 2012 May; 35(5):276-80. PubMed ID: 22539305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. [corrected].
    Tracy CM; Epstein AE; Darbar D; DiMarco JP; Dunbar SB; Estes NA; Ferguson TB; Hammill SC; Karasik PE; Link MS; Marine JE; Schoenfeld MH; Shanker AJ; Silka MJ; Stevenson LW; Stevenson WG; Varosy PD; Ellenbogen KA; Freedman RA; Gettes LS; Gillinov AM; Gregoratos G; Hayes DL; Page RL; Stevenson LW; Sweeney MO; ; ;
    Circulation; 2012 Oct; 126(14):1784-800. PubMed ID: 22965336
    [No Abstract]   [Full Text] [Related]  

  • 17. Electromagnetic Interference (EMI) and arrhythmic events in ICD patients undergoing gastrointestinal procedures.
    Guertin D; Faheem O; Ling T; Pelletier G; McComas D; Yarlagadda RK; Clyne C; Kluger J
    Pacing Clin Electrophysiol; 2007 Jun; 30(6):734-9. PubMed ID: 17547605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indications for pacemakers, implantable cardioverter-defibrillator and cardiac resynchronization devices.
    Samii SM
    Med Clin North Am; 2015 Jul; 99(4):795-804. PubMed ID: 26042883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ACCF/HRS/AHA/ASE/HFSA/SCAI/SCCT/SCMR 2013 appropriate use criteria for implantable cardioverter-defibrillators and cardiac resynchronization therapy: a report of the American College of Cardiology Foundation appropriate use criteria task force, Heart Rhythm Society, American Heart Association, American Society of Echocardiography, Heart Failure Society of America, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance.
    Russo AM; Stainback RF; Bailey SR; Epstein AE; Heidenreich PA; Jessup M; Kapa S; Kremers MS; Lindsay BD; Stevenson LW
    Heart Rhythm; 2013 Apr; 10(4):e11-58. PubMed ID: 23473952
    [No Abstract]   [Full Text] [Related]  

  • 20. Implantable rhythm devices and electromagnetic interference: myth or reality?
    Dyrda K; Khairy P
    Expert Rev Cardiovasc Ther; 2008 Jul; 6(6):823-32. PubMed ID: 18570620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.